Search Results - "Molina Cerrillo, Javier"

Tumor‐associated macrophages: “Good cop‐bad cop” by Molina‐Cerrillo, Javier, Alonso‐Gordoa, Teresa, Garrido, Pilar

Get full text

Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study) by Ciccarese, Chiara, Büttner, Thomas, Cerbone, Linda, Zampiva, Ilaria, Monteiro, Fernando Sabino M, Basso, Umberto, Pichler, Martin, Vitale, Maria Giuseppa, Fiala, Ondrej, Roviello, Giandomenico, Kopp, Ray Manneh, Carrozza, Francesco, Pichler, Renate, Grillone, Francesco, Calabuig, Esther Pérez, Zeppellini, Annalisa, Küronya, Zsófia, Galli, Luca, Facchini, Gaetano, Sunela, Kaisa, Mosca, Alessandra, Molina-Cerrillo, Javier, Spinelli, Gian Paolo, Ansari, Jawaher, Scala, Alessandro, Mollica, Veronica, Grande, Enrique, Buti, Sebastiano, Kanesvaran, Ravindran, Zakopoulou, Roubini, Bamias, Aristotelis, Rizzo, Mimma, Massari, Francesco, Iacovelli, Roberto, Santoni, Matteo

“…Metastatic renal cell carcinoma (mRCC) carrying sarcomatoid features (sRCC) has aggressive biology and poor prognosis. First-line immunotherapy (IO)-based…”
Get full text

The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE‐1407) by Grande, Enrique, Teulé, Alex, Alonso‐Gordoa, Teresa, Jiménez‐Fonseca, Paula, Benavent, Marta, Capdevila, Jaume, Custodio, Ana, Vera, Ruth, Munarriz, Javier, La Casta, Adelaida, Díez, Juan José, Gajate, Pablo, Molina‐Cerrillo, Javier, Matos, Ignacio, Cristóbal, Eva María, Ruffinelli, José C., Palacios, José, García‐Carbonero, Rocío

“…Lessons Learned Palbociclib demonstrated no detectable activity in molecularly unselected and heavily pretreated patients with advanced grade 1/2 pancreatic…”
Get full text

Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long‐Term Efficacy in a Patient with Gastrointestinal Neuroendocrine Tumor by Molina‐Cerrillo, Javier, Grande, Enrique, Alonso‐Gordoa, Teresa

“…In this article, we propose, based on a clinical case, the potential antitumor effect related to the inhibition of serotonin in neuroendocrine tumors (NETs)…”
Get full text

Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys" by Alonso-Gordoa, Teresa, García-Bermejo, María Laura, Grande, Enrique, Garrido, Pilar, Carrato, Alfredo, Molina-Cerrillo, Javier

“…Clear cell renal cell carcinoma (ccRCC) is the seventh most frequently diagnosed tumor in adults in Europe and represents approximately 2.5% of cancer deaths…”
Get full text

Tyrosine Kinase Receptors in Oncology by Esteban-Villarrubia, Jorge, Soto-Castillo, Juan José, Pozas, Javier, San Román-Gil, María, Orejana-Martín, Inmaculada, Torres-Jiménez, Javier, Carrato, Alfredo, Alonso-Gordoa, Teresa, Molina-Cerrillo, Javier

“…Tyrosine kinase receptors (TKR) comprise more than 60 molecules that play an essential role in the molecular pathways, leading to cell survival and…”
Get full text

Sunitinib and Evofosfamide (TH‐302) in Systemic Treatment‐Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE‐1408 Trial by Grande, Enrique, Rodriguez‐Antona, Cristina, López, Carlos, Alonso‐Gordoa, Teresa, Benavent, Marta, Capdevila, Jaume, Teulé, Alex, Custodio, Ana, Sevilla, Isabel, Hernando, Jorge, Gajate, Pablo, Molina‐Cerrillo, Javier, Díez, Juan José, Santos, María, Lanillos, Javier, García‐Carbonero, Rocío

“…Background Sunitinib (SUN)‐induced hypoxia within the tumor could promote the activation of the prodrug evofosfamide (EVO), locally releasing the cytotoxic DNA…”
Get full text

Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms by Pozas, Javier, San Román, María, Alonso-Gordoa, Teresa, Pozas, Miguel, Caracuel, Laura, Carrato, Alfredo, Molina-Cerrillo, Javier

“…Despite being infrequent tumors, the incidence and prevalence of pancreatic neuroendocrine tumors (P-NETs) has been rising over the past few decades. In recent…”
Get full text

Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments by Cortés, Alfonso, Casado, José L., Longo, Federico, Serrano, Juan J., Saavedra, Cristina, Velasco, Héctor, Martin, Adrián, Chamorro, Jesús, Rosero, Diana, Fernández, María, Gion, María, Martínez Jáñez, Noelia, Soria Rivas, Ainara, Alonso Gordoa, Teresa, Martínez Delfrade, Íñigo, Lage, Yolanda, López Miranda, Elena, Olmedo, María E., Reguera Puertas, Pablo, Gajate, Pablo, Molina Cerrillo, Javier, Guerra Alia, Eva, Fuentes Mateos, Raquel, Romero, Beatriz, Rodríguez-Domínguez, Mario J., Vallejo, Alejandro, Carrato, Alfredo

“…Patients with cancer (PC) are at high risk of acquiring COVID-19 and can develop more serious complications. Deeper understanding of vaccines immunogenicity in…”
Get full text

Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors by Molina‐Cerrillo, Javier, Alonso‐Gordoa, Teresa, Martínez‐Sáez, Olga, Grande, Enrique

“…The carcinoid syndrome represents a set of signs and symptoms associated with neuroendocrine tumors (NETs) that occur primarily when metastases are developed…”
Get full text

Novel Tyrosine Kinase Targets in Urothelial Carcinoma by Torres-Jiménez, Javier, Albarrán-Fernández, Víctor, Pozas, Javier, Román-Gil, María San, Esteban-Villarrubia, Jorge, Carrato, Alfredo, Rosero, Adriana, Grande, Enrique, Alonso-Gordoa, Teresa, Molina-Cerrillo, Javier

“…Urothelial carcinoma represents one of the most prevalent types of cancer worldwide, and its incidence is expected to grow. Although the treatment of the…”
Get full text

Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy by San Román Gil, María, Pozas, Javier, Molina-Cerrillo, Javier, Gómez, Joaquín, Pian, Héctor, Pozas, Miguel, Carrato, Alfredo, Grande, Enrique, Alonso-Gordoa, Teresa

“…Thyroid cancer represents a heterogenous disease whose incidence has increased in the last decades. Although three main different subtypes have been described,…”
Get full text

Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance by Araujo-Castro, Marta, Pascual-Corrales, Eider, Molina-Cerrillo, Javier, Alonso-Gordoa, Teresa

“…Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with limited treatment options in the advanced stages. Immunotherapy offers hope for altering the…”
Get full text

Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs by Moreno, Elisa Conde, Pascual, Alejandro, Prieto-Cuadra, Daniel, Laza, Val F, Molina-Cerrillo, Javier, Ramos-Muñoz, Miren Edurne, Rodríguez-Serrano, Esperanza Macarena, Soto, José Luis, Carrato, Alfredo, García-Bermejo, María Laura, Guillén-Ponce, Carmen

“…microRNAs (miRNA) expression in colorectal (CR) primary tumours can facilitate a more precise molecular characterization. We identified and validated a miRNA…”
Get full text

May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia by Molina-Cerrillo, Javier, Marquet-Palomanes, Juan, Alonso-Gordoa, Teresa, López-Jiménez, Javier, Grande, Enrique

“…COVID-19 is affecting many countries all around the world. Unfortunately, no treatment has already been approved for the management of patients infected by…”
Get full text

The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide by Serrano Domingo, Juan José, Alonso Gordoa, Teresa, Lorca Álvaro, Javier, Molina-Cerrillo, Javier, Barquín García, Arantzazu, Martínez Sáez, Olga, Burgos Revilla, Javier, Carrato, Alfredo, Álvarez Rodríguez, Sara

“…Introduction: Androgenic deprivation therapies have been linked to the development of metabolic syndrome (MS) and cardiovascular diseases, which may lead to a…”
Get full text

Primary Neuroendocrine Tumor of the Parotid Gland: A Case Report and a Comprehensive Review of a Rare Entity by Martínez-Sáez, Olga, Molina-Cerrillo, Javier, Moreno García del Real, Carmen, Barberá Durban, Rafael, Díez, Juan J., Alonso-Gordoa, Teresa, Pulido, Enrique Grande

“…Neuroendocrine tumors (NETs) comprise a heterogeneous group of malignancies from cells derived from the neural crest with neuroendocrine differentiation…”
Get full text

Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis by Santoni, Matteo, Rizzo, Alessandro, Kucharz, Jakub, Mollica, Veronica, Rosellini, Matteo, Marchetti, Andrea, Tassinari, Elisa, Monteiro, Fernando Sabino Marques, Soares, Andrey, Molina-Cerrillo, Javier, Grande, Enrique, Battelli, Nicola, Massari, Francesco

“…Background Immunotherapy has determined unprecedented long-term responses in several hematological and solid tumors. In the MOUSEION-03 study, we conducted a…”
Get full text

Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy by Martínez-Sáez, Olga, Borau, Pablo Gajate, Alonso-Gordoa, Teresa, Molina-Cerrillo, Javier, Grande, Enrique

“…Highlights • Antiangiogenic therapies are key therapeutic agents in ccRCC. • The evidence suggests that HIF-2α subunit has a central role in ccRCC over HIF-1α…”
Get full text

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation by Molina-Cerrillo, Javier, Alonso-Gordoa, Teresa, Carrato, Alfredo, Grande, Enrique

Get full text